Artificial intelligence and drug discovery Free

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

x Mobile version: slides + audio only
-15s 00:00 / 17:32 +15s
Minimise video

Ms Jackie Hunter discusses the value and potential impact of Artificial Intelligence on the pharmaceutical industry in regards to drug discovery.  Ms Hunter looks at the proof of the principle being used already, and how it may work in a clinic setting. 

This lecture was filmed at the "The 14th Medical Innovations Summit" event at the Royal Society of Medicine in London.

Date of lecture: 22nd of April 2017

Length: 00:17:32

00:00:01 - Introduction
00:01:38 - Why Drug Discovery Needs AI
00:06:30 - Data's Role in Drug Discovery
00:15:22 - Conclusion
00:00:01
00:00:18
00:01:00
00:01:18
00:01:38
00:03:25
00:04:05
00:05:00
00:05:49
00:06:30
00:07:10
00:08:44
00:09:30
00:10:39
00:11:40
00:13:51
00:15:22
00:16:47
51:06

Professor Sir Mark Walport, Director of the Wellcome Trust.

Archived View
35:53

Mr Ben Challacombe, Consultant Urological Surgeon at Guy's and St Thomas' NHS Foundation Trust.

 

Free Archived View
38:25

Professor Tom Waddell, Professor of Thoracic and Lung Transplant Surgery, University of Toronto.

Archived View
25:30

Professor Adrian Hill, Chairman of the Centre for Clinical Vaccinology and Tropical Medicine at Oxford University. 

Free Archived View
28:05

Dr Alun Morgan and Mrs Gill Davies, ZooBiotic.

Free Archived View
26:45

Dr Paul Sobotka, Ardian, California and Dr Mel Lobo, Barts and the London NHS Trust. 

Free Archived View
29:24

Peter Suma and Peter Ellis, Pharmatrust, Canada and the UK.

Free Archived View
37:46

Dr Frederic Moll, President and CEO Hansen Medical Inc, California.

Free Archived View
16:14

Professor Anan Shetty, Senior tutor in orthopaedics, University of London. 

Free Archived View